- Home
- KFFB vs CASI Comparison
KFFB vs CASI Comparison
Compare KFFB & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KFFB | CASI |
|---|---|---|
| Founded | 2005 | 1991 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.5M | 24.9M |
| IPO Year | 2005 | 1996 |
Fundamental Metrics
Financial Performance| Metric | KFFB | CASI |
|---|---|---|
| Price | $4.31 | $0.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 2.9K | ★ 29.1K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | $9,467,000.00 | ★ $26,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $66.85 | ★ N/A |
| Revenue Growth | ★ 26.65 | 21.72 |
| 52 Week Low | $1.96 | $0.93 |
| 52 Week High | $4.97 | $4.05 |
Technical Indicators
Market Signals| Indicator | KFFB | CASI |
|---|---|---|
| Relative Strength Index (RSI) | 53.95 | 29.70 |
| Support Level | $4.19 | $0.93 |
| Resistance Level | $4.44 | $1.25 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 24.14 | 11.48 |
Price Performance
Historical ComparisonAbout KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.